This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid025I
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid025I.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org





{{tp|p=33484168|t=2021. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19.|pdf=|usr=}}
{{tp|p=33399182|t=2021. Herd Immunity to COVID-19.|pdf=|usr=}}
{{tp|p=33469560|t=2021. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS).|pdf=|usr=}}
{{tp|p=33521168|t=2020. Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications.|pdf=|usr=}}
{{tp|p=33406838|t=2021. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.|pdf=|usr=}}
{{tp|p=33458987|t=2021. Sindrome inflamatorio multisistemico en ninos, relacionado con COVID-19: actualizacion a proposito de la presentacion de 2 pacientes criticos.|pdf=|usr=}}
{{tp|p=33458972|t=2021. Tormenta de citoquinas y tormenta de informacion asociadas a COVID-19: consideraciones sobre el sindrome inflamatorio multisistemico en ninos.|pdf=|usr=}}
{{tp|p=33398692|t=2021. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.|pdf=|usr=}}
{{tp|p=33483791|t=2021. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.|pdf=|usr=}}
{{tp|p=33464421|t=2021. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.|pdf=|usr=}}
{{tp|p=33462671|t=2021. The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.|pdf=|usr=}}
{{tp|p=33521335|t=2021. The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve.|pdf=|usr=}}
{{tp|p=33506114|t=2021. Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan.|pdf=|usr=}}
{{tp|p=33515911|t=2021. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33413979|t=2021. A nidovirus perspective on SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33450483|t=2021. The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.|pdf=|usr=}}
{{tp|p=33484784|t=2021. Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33445785|t=2021. The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.|pdf=|usr=}}
{{tp|p=33486617|t=2021. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=}}
{{tp|p=33484403|t=2021. (1)H, (13)C and (15)N chemical shift assignment of the stem-loop 5a from the 5'-UTR of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33475934|t=2021. (1)H, (13)C and (15)N backbone chemical shift assignments of SARS-CoV-2 nsp3a.|pdf=|usr=}}
{{tp|p=33423172|t=2021. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "The SUD-M and SUD-C domains".|pdf=|usr=}}
{{tp|p=33392924|t=2021. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - mus) dynamics in the C-terminal helix at the dimer interface.|pdf=|usr=}}
{{tp|p=33389548|t=2021. (1)H, (15)N and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the endemic human coronavirus HKU1.|pdf=|usr=}}
{{tp|p=33504682|t=2021. Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=33484712|t=2021. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein.|pdf=|usr=}}
{{tp|p=33460600|t=2021. Improving SARS-CoV-2 structures: Peer review by early coordinate release.|pdf=|usr=}}
{{tp|p=33401144|t=2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.|pdf=|usr=}}
{{tp|p=33407800|t=2021. Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33419930|t=2021. What are SARS-CoV-2 genomes from the WHO Africa region member states telling us?|pdf=|usr=}}
{{tp|p=33479725|t=2021. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.|pdf=|usr=}}
{{tp|p=33491070|t=2021. Noncoding RNAs: modulators and modulatable players during infection-induced stress response.|pdf=|usr=}}
{{tp|p=33405097|t=2021. SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.|pdf=|usr=}}
{{tp|p=33448856|t=2021. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches.|pdf=|usr=}}
{{tp|p=33426894|t=2021. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.|pdf=|usr=}}
{{tp|p=33426872|t=2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.|pdf=|usr=}}
{{tp|p=33400372|t=2021. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=33485447|t=2021. Neuropathology associated with SARS-CoV-2 infection - Authors' reply.|pdf=|usr=}}
{{tp|p=33485446|t=2021. Neuropathology associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33485445|t=2021. Neuropathology associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33485444|t=2021. Neuropathology associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33453781|t=2021. Using EM data to understand COVID-19 pathophysiology - Authors' reply.|pdf=|usr=}}
{{tp|p=33453779|t=2021. Using EM data to understand COVID-19 pathophysiology.|pdf=|usr=}}
{{tp|p=33450180|t=2021. First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.|pdf=|usr=}}
{{tp|p=33417829|t=2021. New variant of SARS-CoV-2 in UK causes surge of COVID-19.|pdf=|usr=}}
{{tp|p=33392518|t=2021. SARS-CoV-2 serological cross-reactivity with autoantibodies - Authors' reply.|pdf=|usr=}}
{{tp|p=33392517|t=2021. SARS-CoV-2 serological cross-reactivity with autoantibodies.|pdf=|usr=}}
{{tp|p=33454368|t=2021. Monocytes and macrophages in COVID-19: Friends and foes.|pdf=|usr=}}
{{tp|p=33453245|t=2021. The proteomic characteristics of airway mucus from critical ill COVID-19 patients.|pdf=|usr=}}
{{tp|p=33508291|t=2021. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.|pdf=|usr=}}
{{tp|p=33468702|t=2021. SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.|pdf=|usr=}}
{{tp|p=33468697|t=2021. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.|pdf=|usr=}}
{{tp|p=33468695|t=2021. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.|pdf=|usr=}}
{{tp|p=33436436|t=2021. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?|pdf=|usr=}}
{{tp|p=33511329|t=2020. Adhesive contact between cylindrical (Ebola) and spherical (SARS-CoV-2) viral particles and a cell membrane.|pdf=|usr=}}
{{tp|p=33412501|t=2021. Polycations and polyanions in SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33505220|t=2021. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.|pdf=|usr=}}
{{tp|p=33414350|t=2021. Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru.|pdf=|usr=}}
{{tp|p=33414330|t=2021. Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates.|pdf=|usr=}}
{{tp|p=33414329|t=2021. Genome Sequences of Two GH Clade SARS-CoV-2 Strains Isolated from Patients with COVID-19 in South Korea.|pdf=|usr=}}
{{tp|p=33509997|t=2021. Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy.|pdf=|usr=}}
{{tp|p=33509993|t=2021. Genome Sequences of 10 SARS-CoV-2 Viral Strains Obtained by Nanopore Sequencing of Nasopharyngeal Swabs in Malta.|pdf=|usr=}}
{{tp|p=33509990|t=2021. Genome Sequencing of a Novel Coronavirus SARS-CoV-2 Isolate from Iraq.|pdf=|usr=}}
{{tp|p=33479004|t=2021. Expression of Concern for Sah et al., "Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal".|pdf=|usr=}}
{{tp|p=33401565|t=2021. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.|pdf=|usr=}}
{{tp|p=33445583|t=2021. Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers.|pdf=|usr=}}
{{tp|p=33476315|t=2021. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.|pdf=|usr=}}
{{tp|p=33386849|t=2021. Population dynamics and structural effects at short and long range support the hypothesis of the selective advantage of the G614 SARS-Cov2 spike variant.|pdf=|usr=}}
{{tp|p=33417854|t=2021. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33444546|t=2021. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.|pdf=|usr=}}
{{tp|p=33474931|t=2021. Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions.|pdf=|usr=}}
{{tp|p=33420022|t=2021. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.|pdf=|usr=}}
{{tp|p=33397909|t=2021. Neutralizing antibody titres in SARS-CoV-2 infections.|pdf=|usr=}}
{{tp|p=33397903|t=2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.|pdf=|usr=}}
{{tp|p=33504779|t=2021. Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.|pdf=|usr=}}
{{tp|p=33483492|t=2021. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.|pdf=|usr=}}
{{tp|p=33479198|t=2021. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.|pdf=|usr=}}
{{tp|p=33431842|t=2021. Stabilizing the closed SARS-CoV-2 spike trimer.|pdf=|usr=}}
{{tp|p=33402727|t=2021. Endemic SARS-CoV-2 will maintain post-pandemic immunity.|pdf=|usr=}}
{{tp|p=33442033|t=2021. What have we learnt so far from COVID-19?|pdf=|usr=}}
{{tp|p=33432128|t=2021. Super(antigen) target for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33425367|t=2021. A single nucleotide distinguishes the SARS-CoV-2 in the Wuhan outbreak in December 2019 from that in Beijing-Xinfadi in June 2020, China.|pdf=|usr=}}
{{tp|p=33398006|t=2021. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses.|pdf=|usr=}}
{{tp|p=33381273|t=2020. SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?|pdf=|usr=}}
{{tp|p=33391390|t=2021. SARS-CoV-2 paediatric inflammatory syndrome.|pdf=|usr=}}
{{tp|p=33479801|t=2021. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33437273|t=2021. Real-Time Polymerase chain reaction trends in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33401530|t=2021. SARS-CoV-2-Cholesterol Interaction: A Lot of Food for Thought.|pdf=|usr=}}
{{tp|p=33428826|t=2021. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=33433671|t=2021. Extracardiac imaging findings in COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=33404786|t=2021. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.|pdf=|usr=}}
{{tp|p=33505806|t=2021. Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33391880|t=2020. Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia.|pdf=|usr=}}
{{tp|p=33384909|t=2020. Mutational spectra of SARS-CoV-2 isolated from animals.|pdf=|usr=}}
{{tp|p=33382773|t=2020. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.|pdf=|usr=}}
{{tp|p=33382764|t=2020. Antibody response to SARS-CoV-2 infection in humans: A systematic review.|pdf=|usr=}}
{{tp|p=33382687|t=2020. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.|pdf=|usr=}}
{{tp|p=33507952|t=2021. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.|pdf=|usr=}}
{{tp|p=33493182|t=2021. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.|pdf=|usr=}}
{{tp|p=33476327|t=2021. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.|pdf=|usr=}}
{{tp|p=33465137|t=2021. The coronavirus proofreading exoribonuclease mediates extensive viral recombination.|pdf=|usr=}}
{{tp|p=33411764|t=2021. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.|pdf=|usr=}}
{{tp|p=33395426|t=2021. The role of Neuropilin-1 in COVID-19.|pdf=|usr=}}
{{tp|p=33399747|t=2020. Sindrome inflamatorio multisistemico asociado con SARS-CoV-2 en pediatria.|pdf=|usr=}}
{{tp|p=33399746|t=2020. Sindrome inflamatorio multisistemico temporal asociado con SARS-CoV-2 pediatrico: inverted question markComo nos enfrentamos a un enemigo impredecible?|pdf=|usr=}}
{{tp|p=33411967|t=2021. Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma.|pdf=|usr=}}
{{tp|p=33414185|t=2021. Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'.|pdf=|usr=}}
{{tp|p=33414184|t=2021. Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'' by Tampe et al.|pdf=|usr=}}
{{tp|p=33446481|t=2021. Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds.|pdf=|usr=}}
{{tp|p=33380408|t=2020. Covid-19: Antibodies protect against reinfection for at least six months, study finds.|pdf=|usr=}}
{{tp|p=33464010|t=2021. COVID-19-Related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn.|pdf=|usr=}}
{{tp|p=33414238|t=2021. Inflammatory Bowel Disease Presenting With Concurrent COVID-19 Multisystem Inflammatory Syndrome.|pdf=|usr=}}

{{tp|p=33505752|t=2021. COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm.|pdf=|usr=}}
{{tp|p=33382968|t=2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.|pdf=|usr=}}
{{tp|p=33412089|t=2021. COVID-19-neutralizing antibodies predict disease severity and survival.|pdf=|usr=}}
{{tp|p=33497610|t=2021. Adaptive immunity to SARS-CoV-2 and COVID-19.|pdf=|usr=}}
{{tp|p=33516131|t=2021. Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33441142|t=2021. On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.|pdf=|usr=}}
{{tp|p=33500559|t=2021. Antibodies, epicenter of SARS-CoV-2 immunology.|pdf=|usr=}}
{{tp|p=33510134|t=2021. N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33479219|t=2021. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region.|pdf=|usr=}}
{{tp|p=33388094|t=2021. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.|pdf=|usr=}}
{{tp|p=33483707|t=2021. Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients.|pdf=|usr=}}
{{tp|p=33473190|t=2021. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response.|pdf=|usr=}}
{{tp|p=33420358|t=2021. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.|pdf=|usr=}}
{{tp|p=33420356|t=2021. The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity.|pdf=|usr=}}
{{tp|p=33408342|t=2021. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.|pdf=|usr=}}
{{tp|p=33449149|t=2021. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release.|pdf=|usr=}}
{{tp|p=33503420|t=2021. The immunodominant and neutralization linear epitopes for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33440148|t=2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.|pdf=|usr=}}
{{tp|p=33417835|t=2021. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.|pdf=|usr=}}
{{tp|p=33485405|t=2021. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.|pdf=|usr=}}
{{tp|p=33500101|t=2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.|pdf=|usr=}}
{{tp|p=33495758|t=2021. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.|pdf=|usr=}}
{{tp|p=33495757|t=2021. Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19.|pdf=|usr=}}
{{tp|p=33495756|t=2021. Use of machine learning to identify a T cell response to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33420426|t=2021. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.|pdf=|usr=}}
{{tp|p=33450186|t=2021. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.|pdf=|usr=}}
{{tp|p=33518776|t=2020. Computed optical spectra of SARS-CoV-2 proteins.|pdf=|usr=}}
{{tp|p=33445833|t=2021. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=33417689|t=2021. Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=33400782|t=2021. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.|pdf=|usr=}}
{{tp|p=33395482|t=2021. SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.|pdf=|usr=}}
{{tp|p=33388756|t=2021. Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.|pdf=|usr=}}
{{tp|p=33501951|t=2021. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.|pdf=|usr=}}
{{tp|p=33501950|t=2021. Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.|pdf=|usr=}}
{{tp|p=33386403|t=2021. SARS-CoV-2 immunity and reinfection.|pdf=|usr=}}
{{tp|p=33479086|t=2021. Lessons of the month: A misunderstood teenager with paediatric inflammatory multisystem syndrome - temporarily associated with SARS-CoV-2 admitted under adult medicine.|pdf=|usr=}}
{{tp|p=33524589|t=2021. A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity.|pdf=|usr=}}
{{tp|p=33482352|t=2021. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study.|pdf=|usr=}}
{{tp|p=33465499|t=2021. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient.|pdf=|usr=}}
{{tp|p=33450388|t=2021. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays.|pdf=|usr=}}
{{tp|p=33484220|t=2021. Development of a SARS-CoV-2 rapid antibody detection kit and study on dynamic changes in antibodies in infected patients.|pdf=|usr=}}
{{tp|p=33389315|t=2021. Haemophagocytic syndrome and COVID-19.|pdf=|usr=}}
{{tp|p=33520118|t=2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=33506994|t=2021. Different hair loss patterns in two pediatric patients with COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=33522642|t=2021. Syncytia formation by SARS-CoV-2-infected cells.|pdf=|usr=}}
{{tp|p=33522893|t=2021. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.|pdf=|usr=}}
{{tp|p=33401657|t=2021. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=33497356|t=2021. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.|pdf=|usr=}}
{{tp|p=33492309|t=2021. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.|pdf=|usr=}}
{{tp|p=33427749|t=2021. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.|pdf=|usr=}}
{{tp|p=33467466|t=2021. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.|pdf=|usr=}}
{{tp|p=33399879|t=2021. Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells.|pdf=|usr=}}
{{tp|p=33465066|t=2021. Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.|pdf=|usr=}}
{{tp|p=33411735|t=2021. COVID-19, leprosy, and neutrophils.|pdf=|usr=}}
{{tp|p=33513195|t=2021. High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration.|pdf=|usr=}}
{{tp|p=33507994|t=2021. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.|pdf=|usr=}}
{{tp|p=33497392|t=2021. Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains.|pdf=|usr=}}
{{tp|p=33493185|t=2021. T cell response to SARS-CoV-2 infection in humans: A systematic review.|pdf=|usr=}}
{{tp|p=33479167|t=2021. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.|pdf=|usr=}}
{{tp|p=33446512|t=2021. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.|pdf=|usr=}}
{{tp|p=33406522|t=2021. Genetic Variation and Evolution of the 2019 Novel Coronavirus.|pdf=|usr=}}
{{tp|p=33460776|t=2021. Can efficient stimulation of myogenic microcirculatory oscillations by transient ischemia predict low incidence of COVID-19 infection?|pdf=|usr=}}
{{tp|p=33472605|t=2021. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19.|pdf=|usr=}}
{{tp|p=33495715|t=2021. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.|pdf=|usr=}}
{{tp|p=33495714|t=2021. Binding of the SARS-CoV-2 Spike Protein to Glycans.|pdf=|usr=}}
{{tp|p=33420163|t=2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.|pdf=|usr=}}
{{tp|p=33510359|t=2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.|pdf=|usr=}}
{{tp|p=33510353|t=2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.|pdf=|usr=}}
{{tp|p=33510275|t=2021. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.|pdf=|usr=}}
{{tp|p=33504824|t=2021. Altered high-density lipoprotein composition and functions during severe COVID-19.|pdf=|usr=}}
{{tp|p=33500507|t=2021. CD8(+) T cells predicted the conversion of common covid-19 to severe.|pdf=|usr=}}
{{tp|p=33479465|t=2021. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.|pdf=|usr=}}
{{tp|p=33432067|t=2021. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.|pdf=|usr=}}
{{tp|p=33514692|t=2021. Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.|pdf=|usr=}}
{{tp|p=33514685|t=2021. Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection.|pdf=|usr=}}
{{tp|p=33462185|t=2021. Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19.|pdf=|usr=}}
{{tp|p=33431822|t=2021. Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein.|pdf=|usr=}}
{{tp|p=33381288|t=2020. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.|pdf=|usr=}}
{{tp|p=33437929|t=2021. Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review.|pdf=|usr=}}
{{tp|p=33432304|t=2021. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.|pdf=|usr=}}
{{tp|p=33426471|t=2021. Is Eye Immune-Privileged to COVID-19 Infection?|pdf=|usr=}}
{{tp|p=33403490|t=2021. Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?|pdf=|usr=}}
{{tp|p=33500718|t=2021. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.|pdf=|usr=}}
{{tp|p=33391477|t=2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.|pdf=|usr=}}
{{tp|p=33457321|t=2020. Can we Turn off the "Covid-Biting-Tail" Inflammation?|pdf=|usr=}}
{{tp|p=33455862|t=2021. Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19.|pdf=|usr=}}
{{tp|p=33451855|t=2021. Dysregulation of Cell Signaling by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33467724|t=2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.|pdf=|usr=}}
{{tp|p=33440622|t=2021. SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.|pdf=|usr=}}
{{tp|p=33413449|t=2021. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.|pdf=|usr=}}
{{tp|p=33450669|t=2021. Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.|pdf=|usr=}}
{{tp|p=33387787|t=2021. Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.|pdf=|usr=}}
{{tp|p=33500788|t=2021. Synonymous mutations and the molecular evolution of SARS-CoV-2 origins.|pdf=|usr=}}
{{tp|p=33500787|t=2021. Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink.|pdf=|usr=}}
{{tp|p=33476695|t=2021. The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.|pdf=|usr=}}
{{tp|p=33418027|t=2021. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=}}
{{tp|p=33499234|t=2021. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy.|pdf=|usr=}}
{{tp|p=33498225|t=2021. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.|pdf=|usr=}}
{{tp|p=33477951|t=2021. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.|pdf=|usr=}}
{{tp|p=33477885|t=2021. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.|pdf=|usr=}}
{{tp|p=33467206|t=2021. MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species.|pdf=|usr=}}
{{tp|p=33440724|t=2021. The Fatty Acid Lipid Metabolism Nexus in COVID-19.|pdf=|usr=}}
{{tp|p=33396605|t=2020. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production.|pdf=|usr=}}
{{tp|p=33419245|t=2020. Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization?|pdf=|usr=}}
{{tp|p=33392306|t=2020. Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes.|pdf=|usr=}}
{{tp|p=33410308|t=2021. Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.|pdf=|usr=}}
{{tp|p=33389884|t=2020. Immune Computation and COVID-19 Mortality: A Rationale for IVIg.|pdf=|usr=}}
{{tp|p=33494667|t=2021. Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis.|pdf=|usr=}}
{{tp|p=33394725|t=2021. Editorial: Do not lose focus on myeloid biology in the era of COVID-19.|pdf=|usr=}}
{{tp|p=33434935|t=2021. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.|pdf=|usr=}}
{{tp|p=33479166|t=2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.|pdf=|usr=}}
{{tp|p=33472860|t=2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.|pdf=|usr=}}

{{tp|p=33432808|t=2021. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.|pdf=|usr=}}
{{tp|p=33458462|t=2021. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.|pdf=|usr=}}
{{tp|p=33489438|t=2020. An unorthodox pathophysiology of severe cases of COVID-19 the weak heme hypothesis.|pdf=|usr=}}
{{tp|p=33434105|t=2021. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport.|pdf=|usr=}}
{{tp|p=33434104|t=2021. Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.|pdf=|usr=}}
{{tp|p=33416946|t=2021. Are all cytokine storms the same?|pdf=|usr=}}
{{tp|p=33407957|t=2021. Junctional tachycardia due to multisystem inflammatory syndrome in children with SARS-CoV-2 infection in a 12-year-old female.|pdf=|usr=}}
{{tp|p=33516277|t=2021. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33521695|t=2021. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.|pdf=|usr=}}
{{tp|p=33387094|t=2021. Kawasaki disease and influenza-new lessons from old associations.|pdf=|usr=}}
{{tp|p=33428101|t=2021. Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=33411143|t=2021. COVID-19, rheumatic diseases and immune dysregulation-a perspective.|pdf=|usr=}}
{{tp|p=33456620|t=2021. Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.|pdf=|usr=}}
{{tp|p=33514825|t=2021. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.|pdf=|usr=}}
{{tp|p=33383528|t=2021. Identification and computational analysis of mutations in SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33456724|t=2021. Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic beta-CoVs.|pdf=|usr=}}
{{tp|p=33425248|t=2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.|pdf=|usr=}}
{{tp|p=33391633|t=2021. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?|pdf=|usr=}}
{{tp|p=33397460|t=2021. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome.|pdf=|usr=}}
{{tp|p=33403180|t=2020. Adult Inflammatory Multi-System Syndrome Mimicking Kawasaki Disease in a Patient With COVID-19.|pdf=|usr=}}
{{tp|p=33425537|t=2020. A Case of Multisystem Inflammatory Syndrome Post-COVID-19 Infection in an Adult.|pdf=|usr=}}
{{tp|p=33457109|t=2021. Decoding Covid-19 with the SARS-CoV-2 Genome.|pdf=|usr=}}
{{tp|p=33508651|t=2021. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?|pdf=|usr=}}
{{tp|p=33487779|t=2020. Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms.|pdf=|usr=}}
{{tp|p=33522107|t=2021. Sustained cellular immunity in adults recovered from mild COVID-19.|pdf=|usr=}}
{{tp|p=33496367|t=2021. A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19.|pdf=|usr=}}
{{tp|p=33422265|t=2021. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.|pdf=|usr=}}
{{tp|p=33436069|t=2021. Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus.|pdf=|usr=}}
{{tp|p=33388575|t=2021. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.|pdf=|usr=}}
{{tp|p=33520333|t=2020. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity.|pdf=|usr=}}
{{tp|p=33427152|t=2021. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children.|pdf=|usr=}}
{{tp|p=33517929|t=2021. Diversity of SARS-CoV-2 isolates driven by pressure and health index.|pdf=|usr=}}
{{tp|p=33462598|t=2021. COVID 19: in the eye of the cytokine storm.|pdf=|usr=}}
{{tp|p=33404891|t=2021. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.|pdf=|usr=}}
{{tp|p=33421274|t=2021. Circulating cardiovascular microRNAs in critically ill COVID-19 patients.|pdf=|usr=}}
{{tp|p=33452570|t=2021. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.|pdf=|usr=}}
{{tp|p=33419887|t=2021. Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=33506945|t=2021. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.|pdf=|usr=}}
{{tp|p=33478625|t=2021. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.|pdf=|usr=}}
{{tp|p=33495994|t=2021. Is lymphopenia different between SARS and COVID-19 patients?|pdf=|usr=}}
{{tp|p=33503469|t=2021. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.|pdf=|usr=}}
{{tp|p=33510633|t=2020. Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.|pdf=|usr=}}
{{tp|p=33520952|t=2020. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.|pdf=|usr=}}
{{tp|p=33521069|t=2020. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.|pdf=|usr=}}
{{tp|p=33505977|t=2020. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=33392109|t=2020. Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2?|pdf=|usr=}}
{{tp|p=33511102|t=2020. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.|pdf=|usr=}}
{{tp|p=33469527|t=2020. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.|pdf=|usr=}}
{{tp|p=33381492|t=2020. Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins.|pdf=|usr=}}
{{tp|p=33488517|t=2020. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=33519902|t=2020. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.|pdf=|usr=}}
{{tp|p=33505425|t=2020. Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences.|pdf=|usr=}}
{{tp|p=33424918|t=2020. A Comprehensive Analysis of cis-Acting RNA Elements in the SARS-CoV-2 Genome by a Bioinformatics Approach.|pdf=|usr=}}
{{tp|p=33519814|t=2020. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.|pdf=|usr=}}
{{tp|p=33519802|t=2020. Does Angiotensin II Peak in Response to SARS-CoV-2?|pdf=|usr=}}
{{tp|p=33424856|t=2020. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.|pdf=|usr=}}
{{tp|p=33391280|t=2020. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.|pdf=|usr=}}
{{tp|p=33384691|t=2020. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.|pdf=|usr=}}
{{tp|p=33392257|t=2020. Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case.|pdf=|usr=}}
{{tp|p=33469522|t=2020. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.|pdf=|usr=}}
{{tp|p=33425823|t=2020. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.|pdf=|usr=}}
{{tp|p=33381049|t=2020. A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface.|pdf=|usr=}}
{{tp|p=33510644|t=2020. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?|pdf=|usr=}}
{{tp|p=33414726|t=2020. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.|pdf=|usr=}}
{{tp|p=33392612|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness.|pdf=|usr=}}
{{tp|p=33403225|t=2020. SARS-CoV-2: A Trigger for Kawasaki Disease or a New Syndrome?|pdf=|usr=}}
{{tp|p=33431578|t=2021. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.|pdf=|usr=}}
{{tp|p=33495741|t=2021. Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa.|pdf=|usr=}}
{{tp|p=33437888|t=2021. Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis.|pdf=|usr=}}
{{tp|p=33524881|t=2021. What do we know about the antibody responses to SARS-CoV-2?|pdf=|usr=}}
{{tp|p=33427136|t=2021. The 501.V2 and B.1.1.7 variants of coronavirus disease 2019 (COVID-19): A new time-bomb in the making?|pdf=|usr=}}
{{tp|p=33521603|t=2021. A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity.|pdf=|usr=}}
{{tp|p=33521593|t=2021. The presentation of SARS-CoV-2 peptides by the common HLA-A( )02:01 molecule.|pdf=|usr=}}
{{tp|p=33480287|t=2021. Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.|pdf=|usr=}}
{{tp|p=33506741|t=2021. Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis.|pdf=|usr=}}
{{tp|p=33513242|t=2021. Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=33524125|t=2021. Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health.|pdf=|usr=}}
{{tp|p=33464307|t=2021. Mapping and role of T cell response in SARS-CoV-2-infected mice.|pdf=|usr=}}
{{tp|p=33431260|t=2021. Reply to letter to the editor: Kawasaki disease and COVID-19: A pretext for a hot topic.|pdf=|usr=}}
{{tp|p=33464637|t=2021. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.|pdf=|usr=}}
{{tp|p=33512021|t=2021. Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.|pdf=|usr=}}
{{tp|p=33506970|t=2021. Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?|pdf=|usr=}}
{{tp|p=33506952|t=2021. Role of Toll-like receptors in the pathogenesis of COVID-19.|pdf=|usr=}}
{{tp|p=33506951|t=2021. Emergence of SARS-CoV-2 Variant: A wake-up call for Pakistan's overburdened healthcare system.|pdf=|usr=}}
{{tp|p=33506950|t=2021. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=33506962|t=2021. A parsimonious approach for recognizing SARS-CoV-2 and host interactions.|pdf=|usr=}}
{{tp|p=33433004|t=2021. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.|pdf=|usr=}}
{{tp|p=33427302|t=2021. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.|pdf=|usr=}}
{{tp|p=33493263|t=2021. Kidney injury molecule-1 is a potential receptor for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33453103|t=2021. Kidney injury molecule-1: a novel entry factor for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33518219|t=2020. Compelling evidence of a novel multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33458751|t=2021. 16 Weeks Later: Expanding the Risk Period for MIS-C.|pdf=|usr=}}
{{tp|p=33500262|t=2021. Covid-19: New UK variant may be linked to increased death rate, early data indicate.|pdf=|usr=}}
{{tp|p=33380449|t=2021. Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=33504377|t=2021. Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT.|pdf=|usr=}}
{{tp|p=33382348|t=2021. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?|pdf=|usr=}}
{{tp|p=33510385|t=2021. The m(6)A methylome of SARS-CoV-2 in host cells.|pdf=|usr=}}
{{tp|p=33394568|t=2021. Illuminating the immunopathology of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33504318|t=2021. An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.|pdf=|usr=}}
{{tp|p=33499661|t=2021. RNA editors: key regulators of viral response in cancer patients.|pdf=|usr=}}
{{tp|p=33467896|t=2021. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.|pdf=|usr=}}
{{tp|p=33435808|t=2021. Immune memory: an evolutionary perspective.|pdf=|usr=}}
{{tp|p=33417561|t=2021. Detection of Phenotype-related Mutations of COVID-19 via the Whole Genomic Data.|pdf=|usr=}}
{{tp|p=33444511|t=2021. Immune response to COVID-19 infection: a double-edged sword.|pdf=|usr=}}
{{tp|p=33443384|t=2021. What Is a Cytokine Storm and Should It Matter to Me?|pdf=|usr=}}
{{tp|p=33412850|t=2021. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.|pdf=|usr=}}
{{tp|p=33427605|t=2021. A genetic element in the SARS-CoV-2 genome is shared with multiple insect species.|pdf=|usr=}}
{{tp|p=33506974|t=2021. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33458832|t=2021. World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.|pdf=|usr=}}
{{tp|p=33386744|t=2021. The dilemma of herd immunity for COVID-19.|pdf=|usr=}}
{{tp|p=33404091|t=2021. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.|pdf=|usr=}}
{{tp|p=33510530|t=2021. Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal.|pdf=|usr=}}

{{tp|p=33399535|t=2021. Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.|pdf=|usr=}}
{{tp|p=33393462|t=2021. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.|pdf=|usr=}}
{{tp|p=33443016|t=2021. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33496249|t=2021. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.|pdf=|usr=}}
{{tp|p=33496647|t=2021. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.|pdf=|usr=}}
{{tp|p=33407005|t=2021. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.|pdf=|usr=}}
{{tp|p=33399033|t=2021. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France.|pdf=|usr=}}
{{tp|p=33399028|t=2021. The interplay between emerging human coronavirus infections and autophagy.|pdf=|usr=}}
{{tp|p=33422505|t=2021. Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung.|pdf=|usr=}}
{{tp|p=33478621|t=2021. Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update.|pdf=|usr=}}
{{tp|p=33413740|t=2021. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.|pdf=|usr=}}
{{tp|p=33400927|t=2021. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?|pdf=|usr=}}
{{tp|p=33504359|t=2021. Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33444084|t=2021. Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children.|pdf=|usr=}}
{{tp|p=33382362|t=2021. Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease.|pdf=|usr=}}
{{tp|p=33500774|t=2020. Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity.|pdf=|usr=}}
{{tp|p=33456761|t=2020. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.|pdf=|usr=}}
{{tp|p=33391730|t=2020. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients.|pdf=|usr=}}
{{tp|p=33467912|t=2021. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).|pdf=|usr=}}
{{tp|p=33484691|t=2021. Reply: Dysbiosis in SARS-CoV-2 infected patients.|pdf=|usr=}}
{{tp|p=33387514|t=2020. Dysbiosis in SARS-CoV-2 infected patients.|pdf=|usr=}}
{{tp|p=33398248|t=2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.|pdf=|usr=}}
{{tp|p=33521382|t=2021. Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes.|pdf=|usr=}}
{{tp|p=33490718|t=2021. Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=33521384|t=2020. Genetic variations among SARS-CoV-2 strains isolated in China.|pdf=|usr=}}
{{tp|p=33503821|t=2021. Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.|pdf=|usr=}}
{{tp|p=33396837|t=2020. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level.|pdf=|usr=}}
{{tp|p=33521209|t=2020. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.|pdf=|usr=}}
{{tp|p=33395363|t=2021. Epigenetic mechanisms influencing COVID-19.|pdf=|usr=}}
{{tp|p=33512495|t=2021. Rapid Spread of Mutant Alleles in Worldwide SARS-CoV-2 Strains Revealed by Genome-Wide Single Nucleotide Polymorphism and Variation Analysis.|pdf=|usr=}}
{{tp|p=33383142|t=2021. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing.|pdf=|usr=}}
{{tp|p=33412761|t=2020. Updated confidence intervals for the COVID-19 antibody retention rate in the Korean population.|pdf=|usr=}}
{{tp|p=33412760|t=2020. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.|pdf=|usr=}}
{{tp|p=33390179|t=2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.|pdf=|usr=}}
{{tp|p=33406391|t=2021. T Cell Memory: Understanding COVID-19.|pdf=|usr=}}
{{tp|p=33382973|t=2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.|pdf=|usr=}}
{{tp|p=33513337|t=2021. B cell memory: understanding COVID-19.|pdf=|usr=}}
{{tp|p=33428993|t=2021. Did we forget the diffuse chemosensory system when studying COVID-19?|pdf=|usr=}}
{{tp|p=33421440|t=2021. Immune reactivity during COVID-19: Implications for treatment.|pdf=|usr=}}
{{tp|p=33400966|t=2021. Are the emerging SARS-COV-2 mutations friend or foe?|pdf=|usr=}}
{{tp|p=33384516|t=2020. Multisystem Inflammatory Syndrome in Children: Clinical Features and Management-Intensive Care Experience from a Pediatric Public Hospital in Western India.|pdf=|usr=}}
{{tp|p=33384501|t=2020. Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus.|pdf=|usr=}}
{{tp|p=33446986|t=2020. COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation.|pdf=|usr=}}
{{tp|p=33403611|t=2021. COVID-19 in a Young Infant - A Fatal Multisystem Inflammatory Disorder.|pdf=|usr=}}
{{tp|p=33508515|t=2021. Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India.|pdf=|usr=}}
{{tp|p=33513449|t=2021. Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients.|pdf=|usr=}}
{{tp|p=33516969|t=2021. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33476804|t=2021. Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs.|pdf=|usr=}}
{{tp|p=33387262|t=2021. Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain.|pdf=|usr=}}
{{tp|p=33385239|t=2021. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.|pdf=|usr=}}
{{tp|p=33521758|t=2020. From Animal to Human: Interspecies Analysis Provides a Novel Way of Ascertaining and Fighting COVID-19.|pdf=|usr=}}
{{tp|p=33498051|t=2021. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.|pdf=|usr=}}
{{tp|p=33486489|t=2021. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency.|pdf=|usr=}}
{{tp|p=33440306|t=2021. An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses.|pdf=|usr=}}
{{tp|p=33401205|t=2021. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33385714|t=2021. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity.|pdf=|usr=}}
{{tp|p=33450373|t=2021. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.|pdf=|usr=}}
{{tp|p=33430309|t=2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.|pdf=|usr=}}
{{tp|p=33430234|t=2021. Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.|pdf=|usr=}}
{{tp|p=33498725|t=2021. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.|pdf=|usr=}}
{{tp|p=33498183|t=2021. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?|pdf=|usr=}}
{{tp|p=33396557|t=2020. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.|pdf=|usr=}}
{{tp|p=33396899|t=2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.|pdf=|usr=}}
{{tp|p=33433784|t=2021. A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.|pdf=|usr=}}
{{tp|p=33386601|t=2021. Two different patterns of lymphocyte alterations in critically ill COVID-19 patients.|pdf=|usr=}}
{{tp|p=33454715|t=2021. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.|pdf=|usr=}}
{{tp|p=33463113|t=2020. Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.|pdf=|usr=}}
{{tp|p=33463127|t=2020. COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.|pdf=|usr=}}
{{tp|p=33437935|t=2021. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.|pdf=|usr=}}
{{tp|p=33421631|t=2021. Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword.|pdf=|usr=}}
{{tp|p=33388272|t=2020. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence.|pdf=|usr=}}
{{tp|p=33493496|t=2021. Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.|pdf=|usr=}}
{{tp|p=33472093|t=2021. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.|pdf=|usr=}}
{{tp|p=33406394|t=2021. Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.|pdf=|usr=}}
{{tp|p=33383088|t=2021. Emergence of a new SARS-CoV-2 variant in the UK.|pdf=|usr=}}
{{tp|p=33487533|t=2021. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.|pdf=|usr=}}
{{tp|p=33411935|t=2021. Early differences in cytokine production distinguish severity of COVID-19.|pdf=|usr=}}
{{tp|p=33502532|t=2021. Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department.|pdf=|usr=}}
{{tp|p=33493287|t=2021. Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis.|pdf=|usr=}}
{{tp|p=33476387|t=2021. Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial.|pdf=|usr=}}
{{tp|p=33433587|t=2021. Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.|pdf=|usr=}}
{{tp|p=33524124|t=2021. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19.|pdf=|usr=}}
{{tp|p=33524110|t=2021. Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19.|pdf=|usr=}}
{{tp|p=33519225|t=2021. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.|pdf=|usr=}}
{{tp|p=33432259|t=2021. Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species.|pdf=|usr=}}
{{tp|p=33429476|t=2021. The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=33506254|t=2021. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.|pdf=|usr=}}
{{tp|p=33513240|t=2021. Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India.|pdf=|usr=}}
{{tp|p=33518372|t=2021. Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.|pdf=|usr=}}
{{tp|p=33521734|t=2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=33521726|t=2020. Immunogenomic phases of COVID-19 and appropriate clinical management.|pdf=|usr=}}
{{tp|p=33521749|t=2021. Cell-Free DNA Tissues-of-Origin by Methylation Profiling Reveals Significant Cell, Tissue and Organ-Specific injury related to COVID-19 Severity.|pdf=|usr=}}
{{tp|p=33521750|t=2020. Vaccination Is the Only Acceptable Path to Herd Immunity.|pdf=|usr=}}
{{tp|p=33521315|t=2021. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.|pdf=|usr=}}
{{tp|p=33427554|t=2021. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.|pdf=|usr=}}
{{tp|p=33514928|t=2021. Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.|pdf=|usr=}}
{{tp|p=33423311|t=2021. Human SARS CoV-2 spike protein mutations.|pdf=|usr=}}
{{tp|p=33415739|t=2021. Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus.|pdf=|usr=}}
{{tp|p=33380494|t=2021. Coronavirus Receptors as Immune Modulators.|pdf=|usr=}}
{{tp|p=33514628|t=2021. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.|pdf=|usr=}}
{{tp|p=33523115|t=2021. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=33404586|t=2021. Genetic Variants of SARS-CoV-2-What Do They Mean?|pdf=|usr=}}
{{tp|p=33393161|t=2021. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.|pdf=|usr=}}
{{tp|p=33432184|t=2021. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.|pdf=|usr=}}
{{tp|p=33442016|t=2021. Immune determinants of COVID-19 disease presentation and severity.|pdf=|usr=}}
{{tp|p=33402708|t=2021. Cold sensitivity of the SARS-CoV-2 spike ectodomain.|pdf=|usr=}}
{{tp|p=33494095|t=2021. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.|pdf=|usr=}}
{{tp|p=33461210|t=2021. Evolution of antibody immunity to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33479534|t=2021. Fast-spreading COVID variant can elude immune responses.|pdf=|usr=}}
{{tp|p=33473223|t=2021. Lessons from the host defences of bats, a unique viral reservoir.|pdf=|usr=}}
{{tp|p=33469239|t=2021. The world needs a single naming system for coronavirus variants.|pdf=|usr=}}
{{tp|p=33429418|t=2021. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.|pdf=|usr=}}

{{tp|p=33515497|t=2021. Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community.|pdf=|usr=}}
{{tp|p=33400131|t=2021. European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients.|pdf=|usr=}}
{{tp|p=33401171|t=2021. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.|pdf=|usr=}}
{{tp|p=33476648|t=2021. SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis.|pdf=|usr=}}
{{tp|p=33434581|t=2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.|pdf=|usr=}}
{{tp|p=33475020|t=2021. Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.|pdf=|usr=}}
{{tp|p=33459964|t=2021. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.|pdf=|usr=}}
{{tp|p=33394320|t=2021. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France.|pdf=|usr=}}
{{tp|p=33387156|t=2021. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.|pdf=|usr=}}
{{tp|p=33402024|t=2021. Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease.|pdf=|usr=}}
{{tp|p=33383190|t=2021. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33508323|t=2021. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications.|pdf=|usr=}}
{{tp|p=33413461|t=2021. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.|pdf=|usr=}}
{{tp|p=33413422|t=2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33380328|t=2020. Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.|pdf=|usr=}}
{{tp|p=33513380|t=2021. Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.|pdf=|usr=}}
{{tp|p=33448184|t=2021. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.|pdf=|usr=}}
{{tp|p=33497357|t=2021. Distinct antibody repertoires against endemic human coronaviruses in children and adults.|pdf=|usr=}}
{{tp|p=33476301|t=2021. Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19.|pdf=|usr=}}
{{tp|p=33497425|t=2021. Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis.|pdf=|usr=}}
{{tp|p=33496683|t=2020. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.|pdf=|usr=}}
{{tp|p=33518995|t=2021. Threats from new variants.|pdf=|usr=}}
{{tp|p=33519006|t=2021. The coronavirus could end up mild like a common cold.|pdf=|usr=}}
{{tp|p=33519005|t=2021. The global threat of the coronavirus variants.|pdf=|usr=}}
{{tp|p=33519003|t=2021. What are the new coronavirus variants?|pdf=|usr=}}
{{tp|p=33521378|t=2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.|pdf=|usr=}}
{{tp|p=33512464|t=2021. How can we interpret SARS-CoV-2 antibody test results?|pdf=|usr=}}
{{tp|p=33469663|t=2021. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.|pdf=|usr=}}
{{tp|p=33493353|t=2021. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review.|pdf=|usr=}}
{{tp|p=33519278|t=2021. Genome composition and genetic characterization of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33519271|t=2021. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.|pdf=|usr=}}
{{tp|p=33482019|t=2021. An increase in CD62L(dim) neutrophils precedes the development of pulmonary embolisms in COVID-19 patients.|pdf=|usr=}}
{{tp|p=33523532|t=2021. Early humoral defence: Contributing to confining COVID-19 to conducting airways?|pdf=|usr=}}
{{tp|p=33521857|t=2021. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.|pdf=|usr=}}
{{tp|p=33443036|t=2020. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.|pdf=|usr=}}
{{tp|p=33436498|t=2021. Cytoplasmic short linear motifs in ACE2 and integrin beta3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy.|pdf=|usr=}}
{{tp|p=33436497|t=2021. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.|pdf=|usr=}}
{{tp|p=33408181|t=2021. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.|pdf=|usr=}}
{{tp|p=33436525|t=2021. Immunological characteristics govern the transition of COVID-19 to endemicity.|pdf=|usr=}}
{{tp|p=33419936|t=2021. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.|pdf=|usr=}}
{{tp|p=33421326|t=2021. First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America.|pdf=|usr=}}
{{tp|p=33506644|t=2021. Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease.|pdf=|usr=}}
{{tp|p=33501730|t=2021. A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.|pdf=|usr=}}
{{tp|p=33452828|t=2021. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.|pdf=|usr=}}
{{tp|p=33524849|t=2021. Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles.|pdf=|usr=}}
{{tp|p=33494661|t=2021. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.|pdf=|usr=}}
{{tp|p=33469204|t=2021. Rogue antibodies could be driving severe COVID-19.|pdf=|usr=}}
{{tp|p=33478949|t=2021. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells.|pdf=|usr=}}
{{tp|p=33510015|t=2021. Insights from SARS-CoV-2 sequences.|pdf=|usr=}}
{{tp|p=33446556|t=2021. Learning the language of viral evolution and escape.|pdf=|usr=}}
{{tp|p=33446540|t=2021. Herd immunity by infection is not an option.|pdf=|usr=}}
{{tp|p=33484868|t=2021. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.|pdf=|usr=}}
{{tp|p=33443366|t=2021. Severe COVID-19: Immunosuppression or Hyperinflammation?|pdf=|usr=}}
{{tp|p=33481684|t=2021. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.|pdf=|usr=}}
{{tp|p=33423443|t=2021. [Immunological research of COVID-19 and emerging infectious diseases].|pdf=|usr=}}